Compositions and methods for treating surgical adhesions

Overview

Information

Number
6689803
Application
10/067467
Filing date
02/05/2002
Issue date
02/10/2004
Inventor(s)
William L. Hunter
US Classification
514/365
View at USPTO

Citations

Sanofi-aventis (10)
ALABAMA AT BIRMINGHAM, UNIVERSITY OF (5)
Bristol-Myers Squibb (5)
Angiotech International (4)
Poly-Med (4)
IPXMEDICAL, LLC (4)
NA (3)
Merrell Dow Pharmaceuticals (3)
Regents of the University of California, The (3)
Pfizer (2)
The United States of America as represented by the Department of Health (2)
The Johns Hopkins University (2)
Children's Medical Center (2)
Eisai Co. (2)
Massachusetts Institute Of Technology (2)
Thomas Jefferson University (2)
UNITED STATES OF AMERICA, THE, AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (2)
PG-TXL (1)
McGill University (1)
Phanos Technologies (1)
COVALON technology (1)
Tapestry Pharmaceuticals (1)
Procter & Gamble (1)
COOK MEDICAL TECHNOLOGIES (1)
Rhone-Poulenc Rorer (1)
HOSTETLER, KARL Y. (1)
Chemex Pharmaceuticals (1)
Celgene (1)
HOSTETLER FAMILY TRUST (1)
Montana State University (1)
Matrix Pharmaceutical (1)
Regents Of The University of Minnesota (1)
SPEED GEL (1)
AMO UPPSALA AB (1)
Vestar (1)
Hospira (1)
Chimerix (1)
ANGIODEVICE INTERNATIONAL (1)
Advanced cardiovascular Systems (1)
Vertex Pharmaceuticals (1)

Abstract

Abstract

Methods and compositions for treating or preventing inflammatory diseases such as psoriasis or multiple sclerosis are provided, comprising the step of delivering to the site of inflammation an anti-microtubule agent, or analogue or derivative thereof.

Assignees with Similar Patents

Angiotech International (19)
PG-TXL (12)
IPXMEDICAL, LLC (8)
ANGIODEVICE INTERNATIONAL (5)
Samyang (5)

Referenced by

Boston Scientific (38)
conextions (19)
CritiTech (17)
broncus medical (16)
Celgene (12)
dfb soria (7)
University of Utah (5)
SurModics (4)
resurge therapeutics (4)
COOK MEDICAL TECHNOLOGIES (2)
Cardiac Pacemakers (2)
Broncus Technologies (2)
Covidien (2)
Industrial Technology research Institute (2)
ROCHE DIAGNOSTICS HEMATOLOGY, INC. (2)
SWEET, RICHARD M. (2)
UNIVERSITY OF BRITISH COLUMBIA, THE (1)
Otago Innovation (1)
Omeros (1)
Remon Medical Technologies (1)
dfb soria ll (1)
critltech (1)
University of Kentucky Research Foundation (1)
Abbott Laboratories (1)
Bristol-Myers Squibb (1)

Tech Analysis

Class Subclass Type Reference Factor Citation Factor Strength Grant time Early grant (%)
514 365 Emerging Sustaining Seminal Medium Average 40.7